EG19690A - Solid oral forms of application containing ifosamide as active substance - Google Patents
Solid oral forms of application containing ifosamide as active substanceInfo
- Publication number
- EG19690A EG19690A EG46991A EG46991A EG19690A EG 19690 A EG19690 A EG 19690A EG 46991 A EG46991 A EG 46991A EG 46991 A EG46991 A EG 46991A EG 19690 A EG19690 A EG 19690A
- Authority
- EG
- Egypt
- Prior art keywords
- ifosamide
- active substance
- solid oral
- oral forms
- application containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4024683 | 1990-08-03 | ||
SG181694A SG181694G (en) | 1990-08-03 | 1994-12-30 | Solid oral administration forms containing ifosfamide as active agent |
Publications (1)
Publication Number | Publication Date |
---|---|
EG19690A true EG19690A (en) | 1995-09-30 |
Family
ID=25895607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG46991A EG19690A (en) | 1990-08-03 | 1991-08-01 | Solid oral forms of application containing ifosamide as active substance |
Country Status (33)
Country | Link |
---|---|
US (1) | US5158776A (lv) |
EP (1) | EP0469440B1 (lv) |
JP (2) | JP3061898B2 (lv) |
KR (1) | KR0177170B1 (lv) |
CN (1) | CN1046851C (lv) |
AR (1) | AR247484A1 (lv) |
AT (1) | ATE110261T1 (lv) |
AU (2) | AU643309B2 (lv) |
BG (1) | BG60900B1 (lv) |
CA (1) | CA2048367C (lv) |
CZ (1) | CZ280475B6 (lv) |
DE (2) | DE59102620D1 (lv) |
DK (1) | DK0469440T3 (lv) |
EG (1) | EG19690A (lv) |
ES (1) | ES2058999T3 (lv) |
FI (1) | FI97951C (lv) |
HK (1) | HK15695A (lv) |
HR (1) | HRP920575B1 (lv) |
HU (1) | HU206268B (lv) |
IE (1) | IE66378B1 (lv) |
IL (1) | IL99031A (lv) |
LT (1) | LT3528B (lv) |
LV (1) | LV10043B (lv) |
MC (1) | MC2274A1 (lv) |
MX (1) | MX9100441A (lv) |
NO (1) | NO178252C (lv) |
NZ (1) | NZ239222A (lv) |
PT (1) | PT98532B (lv) |
RO (1) | RO113611B1 (lv) |
SG (1) | SG181694G (lv) |
SI (1) | SI9111342B (lv) |
SK (2) | SK279740B6 (lv) |
ZA (1) | ZA916124B (lv) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7966694A (en) * | 1993-07-21 | 1996-05-02 | University Of Kentucky Research Foundation, The | A multicompartment hard capsule with control release properties |
ITFI970184A1 (it) * | 1997-07-30 | 1999-01-30 | Menarini Farma Ind | Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico |
DE19733305A1 (de) * | 1997-08-01 | 1999-02-04 | Asta Medica Ag | Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin |
US6103297A (en) * | 1998-01-14 | 2000-08-15 | Matsushita Electronics Corporation | Method of manufacturing cathode-ray tube |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
US20040253307A1 (en) * | 2003-02-04 | 2004-12-16 | Brian Hague | Sugar-free oral transmucosal solid dosage forms and uses thereof |
DE102005008797A1 (de) * | 2005-02-25 | 2006-09-07 | Baxter International Inc., Deerfield | Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung |
CN114010629A (zh) * | 2014-01-06 | 2022-02-08 | 英国神盾Tx股份有限公司 | 三麦芽酚铁的剂量方案 |
GB201418710D0 (en) | 2014-10-21 | 2014-12-03 | Iron Therapeutics Holdings Ag | Dosage regimen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5646807A (en) * | 1979-09-27 | 1981-04-28 | Japan Atom Energy Res Inst | Production of composition of complex gradually releasing physiologically active substance |
DE3111428A1 (de) * | 1981-03-24 | 1982-10-07 | Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld | Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
US4618692A (en) * | 1981-09-03 | 1986-10-21 | Asta-Werke Aktiengesellschaft | 4-carbamoyloxy-oxazaphosphorins |
US5019385A (en) * | 1984-11-09 | 1991-05-28 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Novel lymphopine LK 2 and pharmaceutic compositions containing same |
EP0254902B1 (de) * | 1986-07-11 | 1991-08-28 | ASTA Pharma Aktiengesellschaft | Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung |
DE3804686A1 (de) * | 1988-02-15 | 1989-08-24 | Henkel Kgaa | Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten |
-
1991
- 1991-07-15 RO RO148008A patent/RO113611B1/ro unknown
- 1991-07-24 US US07/733,756 patent/US5158776A/en not_active Expired - Lifetime
- 1991-07-24 ES ES91112368T patent/ES2058999T3/es not_active Expired - Lifetime
- 1991-07-24 DK DK91112368.5T patent/DK0469440T3/da active
- 1991-07-24 MC MC912206A patent/MC2274A1/xx unknown
- 1991-07-24 AT AT91112368T patent/ATE110261T1/de not_active IP Right Cessation
- 1991-07-24 DE DE59102620T patent/DE59102620D1/de not_active Expired - Fee Related
- 1991-07-24 EP EP91112368A patent/EP0469440B1/de not_active Expired - Lifetime
- 1991-07-24 DE DE4124481A patent/DE4124481A1/de not_active Withdrawn
- 1991-07-30 MX MX9100441A patent/MX9100441A/es unknown
- 1991-07-31 JP JP3191414A patent/JP3061898B2/ja not_active Expired - Fee Related
- 1991-08-01 IL IL9903191A patent/IL99031A/en not_active IP Right Cessation
- 1991-08-01 NZ NZ239222A patent/NZ239222A/xx not_active IP Right Cessation
- 1991-08-01 EG EG46991A patent/EG19690A/xx active
- 1991-08-01 BG BG94934A patent/BG60900B1/bg unknown
- 1991-08-01 SI SI9111342A patent/SI9111342B/sl not_active IP Right Cessation
- 1991-08-01 PT PT98532A patent/PT98532B/pt not_active IP Right Cessation
- 1991-08-02 NO NO913019A patent/NO178252C/no not_active IP Right Cessation
- 1991-08-02 CA CA002048367A patent/CA2048367C/en not_active Expired - Lifetime
- 1991-08-02 CN CN91105271A patent/CN1046851C/zh not_active Expired - Fee Related
- 1991-08-02 FI FI913710A patent/FI97951C/fi active
- 1991-08-02 KR KR1019910013365A patent/KR0177170B1/ko not_active IP Right Cessation
- 1991-08-02 ZA ZA916124A patent/ZA916124B/xx unknown
- 1991-08-02 AU AU81589/91A patent/AU643309B2/en not_active Ceased
- 1991-08-02 IE IE277491A patent/IE66378B1/en not_active IP Right Cessation
- 1991-08-02 AR AR91320329A patent/AR247484A1/es active
- 1991-08-02 CZ CS912409A patent/CZ280475B6/cs not_active IP Right Cessation
- 1991-08-02 HU HU912594A patent/HU206268B/hu not_active IP Right Cessation
- 1991-08-02 SK SK2409-91A patent/SK279740B6/sk not_active IP Right Cessation
-
1992
- 1992-09-29 HR HRP-1342/91A patent/HRP920575B1/xx not_active IP Right Cessation
- 1992-10-27 LV LVP-92-172A patent/LV10043B/lv unknown
-
1993
- 1993-08-23 AU AU44836/93A patent/AU649184B2/en not_active Ceased
- 1993-09-03 LT LTIP921A patent/LT3528B/lt not_active IP Right Cessation
-
1994
- 1994-12-30 SG SG181694A patent/SG181694G/en unknown
-
1995
- 1995-02-06 HK HK15695A patent/HK15695A/xx not_active IP Right Cessation
-
1998
- 1998-04-27 SK SK543-98A patent/SK279739B6/sk not_active IP Right Cessation
-
2000
- 2000-01-14 JP JP2000006836A patent/JP3545300B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA908817B (en) | Stable oral composition of zinc | |
GB8502974D0 (en) | Sustained release of active substance | |
IL113818A0 (en) | Pharmaceutical active cns compounds and pharmaceutical compositions containing them | |
HU9303035D0 (en) | N-amino-alkyl-carbonyloxy-alkyl-pyrrol derivatives and insecticidal acaricidal and molluscicidal compositions containing the compounds as active ingredients | |
PL311918A1 (en) | Composition for external application containing an antagonist of p substance | |
HU9300536D0 (en) | Compounds of medical effect | |
HU9301720D0 (en) | Herbicidal preparatives containing substituted 5-amino-pyrazoles as active substance and method for producing said compounds | |
IL117050A0 (en) | Solid active ingredient compositions containing hydroxypropylcellulose | |
EG19690A (en) | Solid oral forms of application containing ifosamide as active substance | |
ZA881373B (en) | Dispenser for the application of active components | |
HUT49456A (en) | Fungicides containing as active substance derivatives of piridil-cycloprophan-carboxamidine | |
PL288950A1 (en) | Apparatu for application of active agent to insects | |
NZ239813A (en) | Fungicidally active compounds, their methods of production and compositions containing them | |
PL316306A1 (en) | Insecticidal composition of active substances | |
AU610175B2 (en) | Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis | |
GB8817176D0 (en) | Combined housing & applicator for cosmetic &c materials | |
HUT51854A (en) | Insecticides containing as active substance derivatives of chrisanthemate | |
HUT48800A (en) | Composition against mollusks containing as active substance 2-/2-chlor-1-metoxi-etoxi/-phenil-methil carbamate | |
ZA908278B (en) | Fungicidal combinations of active compounds | |
GB8332164D0 (en) | Of 4949 physiologically active substance | |
HU9202971D0 (en) | Hetero-polycyclic biocidical compounds and preparatives containing them as active substance | |
HU906379D0 (en) | Producing active substance of medicament | |
AU1546088A (en) | An oral composition containing particles comprising an active substance | |
HU9601052D0 (en) | Insecticidal composition containing combination of active ingredients | |
GB9400970D0 (en) | Manufacture of an oral solid dose form of lactitol |